359 related articles for article (PubMed ID: 20481653)
1. Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.
Dormán G; Cseh S; Hajdú I; Barna L; Kónya D; Kupai K; Kovács L; Ferdinandy P
Drugs; 2010 May; 70(8):949-64. PubMed ID: 20481653
[TBL] [Abstract][Full Text] [Related]
2. Progress in the development of matrix metalloproteinase inhibitors.
Tu G; Xu W; Huang H; Li S
Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
[TBL] [Abstract][Full Text] [Related]
3. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
4. Quest for selectivity in inhibition of matrix metalloproteinases.
Brown S; Meroueh SO; Fridman R; Mobashery S
Curr Top Med Chem; 2004; 4(12):1227-38. PubMed ID: 15320723
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
Pavlaki M; Zucker S
Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: Recent progress and current challenges.
Shi Y; Ma X; Fang G; Tian X; Ge C
NanoImpact; 2021 Jan; 21():100293. PubMed ID: 35559782
[TBL] [Abstract][Full Text] [Related]
7. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
Skiles JW; Gonnella NC; Jeng AY
Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitors.
Ramnath N; Creaven PJ
Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Coussens LM; Fingleton B; Matrisian LM
Science; 2002 Mar; 295(5564):2387-92. PubMed ID: 11923519
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases.
Sang QX; Jin Y; Newcomer RG; Monroe SC; Fang X; Hurst DR; Lee S; Cao Q; Schwartz MA
Curr Top Med Chem; 2006; 6(4):289-316. PubMed ID: 16611144
[TBL] [Abstract][Full Text] [Related]
12. An updated patent therapeutic agents targeting MMPs.
Shi ZG; Li JP; Shi LL; Li X
Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):74-101. PubMed ID: 21854361
[TBL] [Abstract][Full Text] [Related]
13. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.
Skiles JW; Gonnella NC; Jeng AY
Curr Med Chem; 2004 Nov; 11(22):2911-77. PubMed ID: 15544483
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.
Fingleton B
Expert Opin Ther Targets; 2003 Jun; 7(3):385-97. PubMed ID: 12783574
[TBL] [Abstract][Full Text] [Related]
15. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies.
Chau I; Rigg A; Cunningham D
Crit Rev Oncol Hematol; 2003 Feb; 45(2):151-76. PubMed ID: 12604127
[TBL] [Abstract][Full Text] [Related]
17. MMP inhibitors and cancer treatment trials, limitations and hopes for the future.
Tlatli R; El Ayeb M
Arch Inst Pasteur Tunis; 2013; 90(1-4):3-21. PubMed ID: 26012207
[TBL] [Abstract][Full Text] [Related]
18. Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer.
Zhong Y; Lu YT; Sun Y; Shi ZH; Li NG; Tang YP; Duan JA
Expert Opin Drug Discov; 2018 Jan; 13(1):75-87. PubMed ID: 29088927
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.
Winer A; Adams S; Mignatti P
Mol Cancer Ther; 2018 Jun; 17(6):1147-1155. PubMed ID: 29735645
[TBL] [Abstract][Full Text] [Related]
20. An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present).
Banerjee S; Baidya SK; Adhikari N; Jha T
Expert Opin Ther Pat; 2023 Oct; 33(10):631-649. PubMed ID: 37982191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]